Athena deal

ATHN said it will continue to evaluate a potential development compound that was derived under the October 1992 collaboration.

Under the continuing terms of the agreement, ATHN has exclusive rights to commercialize the collaboration's discoveries in North America, while NeuroSearch retains exclusive rights in Scandinavia. Commercial rights to other markets will be equally shared. ...